Medartis Holding AG (XSWX:MED) Total Receivables: CHF59.0 Mil (As of Dec. 2025)


XSWX:MED Medartis Holding AG XSWX:MED
82 GF Score
Price CHF82.80
GF Value CHF105.66
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medartis Holding AG Total Receivables?

Medartis Holding AG XSWX:MED +2.99% 82 Total Receivables is CHF59.0 Mil as of Dec. 2025. GuruFocus rates XSWX:MED with a GF Score™ of 82/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Medartis Holding AG's Total Receivables for the quarter that ended in Dec. 2025 was CHF59.0 Mil.

Medartis Holding AG Total Receivables Related Terms

Medartis Holding AG Total Receivables Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG Total Receivables Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.19 44.81 46.14 46.22 58.98

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.14 49.38 46.22 53.87 58.98
XSWX:MED
82GF Score
Medartis Holding AG XSWX:MED
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of CHF59.0 Mil mean?
Medartis Holding AG (XSWX:MED) has a Total Receivables of CHF59.0 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Medartis Holding AG and its competitors.
Is Medartis Holding AG's Total Receivables too high?
Medartis Holding AG's current Total Receivables is CHF59.0 Mil. Overall, Medartis Holding AG has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Total Receivables compare to ABT and SYK?
Medartis Holding AG's Total Receivables of CHF59.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current Total Receivables is CHF59.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF82.80 — trading 21.6% below its estimated fair value. The current Total Receivables is CHF59.0 Mil. Medartis Holding AG's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Total Receivables is CHF59.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF82.80 is trading 21.6% below its estimated GF Value™ of CHF105.66. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • Total Receivables: CHF59.0 Mil
  • GF Value™: CHF105.66 vs. price of CHF82.80 (21.6% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
82GF Score

Get the complete analysis for XSWX:MED

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF82.80
Price
CHF105.66
GF Value